According to a report by Intel Market Research, the global Rapamycin market was valued at USD 529 million in 2024 and is projected to grow from USD 546 million in 2025 to USD 682 million by 2032, registering a CAGR of 3.6% during the forecast period. The market is experiencing steady growth due to increasing demand for immunosuppressive therapies, expanding organ transplantation procedures, and...